Skip to content

Charles River Laboratories CRL Selling, general and administrative — Asset Impairments and Other Costs

Other product segments

Cost of services provided (excluding amortization of intangible assets)
$21.19M+60.9%

Similar metrics at other companies

The Kraft Heinz Company logo
KHCSelling, general and administrative expenses, excluding impairment losses
$918M+1.5%
Tetra Tech logo
TTEKSelling, General, and Administrative Expenses, Including Depreciation and Amortization of Intangible Assets
$82.63M-1.7%
SPX Technologies logo
SPXCSelling, general and administrative — intangible amortization
$23.3M+18.3%
JBT Marel Corporation logo
JBTMSelling, general and administrative expense
$278.98M+120%
Sysco logo
SYYOther — Selling, general & administrative expense
$32M+6.7%
Amcor logo
AMCRCorporate Segment — Other Asset Impairment Charges
$18M

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:OtherRestructuringCosts.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's selling, general and administrative — asset impairments and other costs.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's selling, general and administrative — asset impairments and other costs?
Charles River Laboratories (CRL) reported selling, general and administrative — asset impairments and other costs of $2.98M in Q1 2026.
How has Charles River Laboratories's selling, general and administrative — asset impairments and other costs changed year-over-year?
Charles River Laboratories's selling, general and administrative — asset impairments and other costs increased by 190.4% year-over-year, from $1.03M to $2.98M.
What is the long-term trend for Charles River Laboratories's selling, general and administrative — asset impairments and other costs?
Over 3 years (2022 to 2025), Charles River Laboratories's selling, general and administrative — asset impairments and other costs has grown at a 83.2% compound annual growth rate (CAGR), from $763K to $4.69M.
What does selling, general and administrative — asset impairments and other costs mean?
This metric tracks non-cash charges related to the write-down of intangible or tangible assets, alongside miscellaneous non-recurring administrative expenses. It reflects the accounting recognition that the carrying value of certain assets within the administrative segment exceeds their recoverable amount. Monitoring these costs helps investors identify potential issues with capital allocation or the long-term viability of administrative infrastructure investments.